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Summary
Objective: To determine whether chondroitin sulphate (CS) impedes the migration of primary articular chondrocytes.
Design: Articular chondrocytes were isolated from young and skeletally mature bovine animals. Boyden chambers were used to quantify chon-
drocyte migration on aggrecan in the presence and absence of CS chains. A novel in vitro model of cell migration into articular cartilage ex-
plants was designed to visualise and quantify the migration of labelled chondrocytes into cartilage matrix which had been treated with
chondroitinase ABC to remove CS chains present.
Results: A consistent trend of increased migration with both age groups of a sub-population of chondrocytes was demonstrated on aggrecan
in the absence of CS. These data were supported by results from the in vitro model of chondrocyte migration which demonstrated increasing
numbers of a chondrocyte sub-population from both age groups of cartilage migrating into the chondroitinase ABC digested cartilage explants
with time in culture. Minimal migration of these chondrocytes was demonstrated into phosphate buffered saline (PBS) treated control explants.
Conclusions: We conﬁrm that a sub-population of chondrocytes isolated from both young and skeletally mature articular cartilages have the
ability to migrate. We also demonstrate that CS chains inhibit the migration of these articular chondrocytes and that their removal by chon-
droitinase ABC digestion enhances the migration of these chondrocytes. Such ﬁndings may provide a clinical application for improving
cell-based cartilage repair strategies by enhancing integration between endogenous and repair tissue.
ª 2007 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
Key words: Chondroitin sulphate, Chondrocyte, Migration, Aggrecan, Glycosaminoglycans, Cartilage.
Abbreviations: ACI autologous chondrocyte implantation, sGAG sulphated glycosaminoglycan, DMEM Dulbecco’s Modiﬁed Eagle’s Medium,
ITS insulinetransferrineselenium, CS chondroitin sulphate, DMMB dimethylmethylene blue, PET polyethylene terephthalate, TAE Tris acetate
EDTA, BSA bovine serum albumin, PBS phosphate buffered saline, PBS-T PBS/Tween 20, FITC ﬂuorescein isothiocyanate, CMFDA
50chloromethylﬂuorescein diacetate, DMSO dimethylsulfoxide.Introduction
Articular cartilage, once injured, does not have the ability to
initiate a repair response. This fact is partially attributed to
the static nature of the resident chondrocytes. Cell-based
methods of surgical repair, such as autologous chondrocyte
implantation (ACI)1 have provided a means for the success-
ful generation of a hyaline-like repair tissue with the correct
biomechanical characteristics of articular cartilage. The
major limitation of this technique, as demonstrated by biop-
sies taken from the repair site, is the lack of lateral integra-
tion between repair tissue and endogenous cartilage2,3.
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855tissue4,5. The reason for this lack of integration is unknown
but may be due, in part, to the lack of migration of the im-
planted chondrocytes and/or the matrix macromolecules
at the wound edge to which the cells are attempting to ad-
here and migrate on.
The ability of isolated chondrocytes to migrate has not
been widely studied6e9 and most have not taken into consid-
eration the nature of the chondrocyte phenotype as well as
the established fact that once plated and passaged, chon-
drocytes will ‘‘de-differentiate’’ into ﬁbroblast-like cells10,11.
It has previously been demonstrated that chondrocytes iso-
lated from newborn calves do have the capacity to migrate
on ﬁbronectin6. However, to date, there have been no re-
ports on the migratory ability of primary chondrocytes iso-
lated from skeletally mature articular cartilage, which is of
particular importance as cell-based methods of surgical re-
pair generally use autologous chondrocytes isolated from
adult articular cartilage. The large aggregating proteoglycan,
aggrecan, is generally considered to be anti-adhesive due to
the presence of its negatively charged sulphated glycosami-
noglycan (sGAG) side chains12e17 and inhibits the migration
of numerous cell types18e21. Surprisingly, there have been
no studies on the effect of aggrecan on chondrocyte migra-
tion. As aggrecan synthesis is known to be up-regulated at
856 L. C. Davies et al.: CS impedes migration in a sub-population of chondrocytesthe wound edge of injured articular cartilage22,23 we hy-
pothesise that this matrix macromolecule may have an inhib-
itory effect on the migration and integration of implanted
chondrocytes into the damaged tissue.
The effects of enzymatically removing proteoglycans
from the wound surface to enhance adhesion of implanted
chondrocytes have been previously investigated21,24,25 but
none have studied whether these adherent chondrocytes
go on to migrate into the digested tissue and adopt the char-
acteristics of the resident cells. Interestingly, some of the
best results have been seen using the enzyme chondroiti-
nase ABC, an endolytic sGAG lyase, which directly targets
the sGAG chains, without damage to the actual architecture
of the cartilage21,24,25.
In this study we demonstrate, for the ﬁrst time, that a sub-
population of primary chondrocytes isolated from both
young and skeletally mature articular cartilages have the
ability to migrate. Using both a Boyden chamber model of
cell migration and an in vitro full thickness articular cartilage
explant model we also conﬁrm that chondroitin sulphate
(CS) impedes the migration of articular chondrocytes and
that prolonged digestion of cartilage with chondroitinase
ABC promotes the migration of isolated chondrocytes into
the digested matrix.Materials and methods
All reagents were purchased from Sigma (Poole, UK) unless otherwise
stated.ISOLATION OF PRIMARY ARTICULAR CARTILAGE
CHONDROCYTESPrimary chondrocytes were isolated from the medial and lateral condyles
of the metacarpophalangeal joint of 7 day and 18e24-month-old bovine an-
imals within 12 h of slaughter, as described previously26. Chondrocytes were
cultured in Dulbecco’s Modiﬁed Eagle’s Medium with Hams F12 (DMEM/
Hams F-12-Glutamax-1, Invitrogen, Paisley, UK) supplemented with
100 U/ml penicillin, 100 mg/ml streptomycin (both Invitrogen, Paisley, UK),
50 mg/ml ascorbate-2-phosphate and 1 insulinetransferrinesodium sele-
nite (ITS) (Invitrogen, Paisley, UK). Supplementation of the media with ITS
has previously been shown to maintain the chondrocytic phenotype in mono-
layer culture27.GENERATION OF A CHONDROITINASE ABC DIGESTED
AGGRECAN SUBSTRATEMonomeric aggrecan, A1D1 fraction, puriﬁed from bovine nasal cartilage
was digested with chondroitinase ABC at a concentration of 0.001 U/10 mg of
sGAG for 24 h at 37C with agitation. Loss of the CS side chains was as-
sessed by both the dimethylmethylene blue (DMMB) colorimetric assay28
and immunochemical slot blotting using the monoclonal antibodies 1-B-5
and 2-B-6 (raised against chondroitinase ABC generated chondroitin-0 and
4-sulphate stubs, respectively)29,30.ASSESSMENT OF CELL MIGRATION: BOYDEN CHAMBER
ASSAYBoyden chamber porous membranes [8 mm pore size polyethylene tere-
phthalate (PET) membrane (Becton Dickinson, USA)] were coated both
sides with 50 mg/ml of either puriﬁed bovine nasal cartilage aggrecan or
chondroitinase ABC treated aggrecan, in 0.1 M Tris-acetate buffer (TAE),
pH 6.8, for 2 h at room temperature. Remaining binding sites were blocked
with 0.1% (w/v) bovine serum albumin (BSA) diluted in phosphate buffered
saline (PBS; pH 7.4) for 1 h at room temperature and washed with PBS prior
to storage at 4C.
Isolated chondrocytes were seeded onto the upper side of the membrane
at a density of 2 105 cells/well as described previously6. Media was added
to the bottom of the well through the sampling port. Chondrocytes were
allowed to adhere to the coated membrane and migration assessed over
a period of 1e24 h.
Non-motile cells were removed from the upper surface of the membrane.
The number of migrated chondrocytes i.e., attached to the underside of themembrane, was quantiﬁed by staining the cells with 0.1% (w/v) crystal violet
dye as described previously6. Stained cells were visualised by inverting the
plate inserts and viewing using an upright light microscope (Laborlux 12,
Leitz DRMB, Leica, Germany) connected to a digital camera (Coolsnap
RS Photometrics, USA). Images from three random visual ﬁelds, of
0.25 mm2, in each well were recorded using the Coolsnap image capture
program version 1.2 (Roper Scientiﬁc Inc., USA). The average number of mi-
grated cells within this 0.25-mm2 ﬁeld was counted, and the total number of
migrated cells was calculated (surface area of Boyden chamber membrane
is 30 mm2). The mean standard error mean (S.E.M.) was calculated for each
group of samples and all data were assessed for normal distribution using
the AndersoneDarling test (P> 0.05). Statistical signiﬁcance was calculated
using a one-way analysis of variance (ANOVA) and Bonferroni post-test
where P< 0.05.DEVELOPMENT OF AN IN VITRO ARTICULAR CARTILAGE
MODELFull thickness articular cartilage explants (5 mm 4 mm) were excised
from themetacarpophalangeal joints of 7-day-old calves using a sharp scalpel
blade and embedded in 2% agarose (Flowgen, UK) equilibrated with media.
The full depth explant was orientated such that only the cut surface was left ex-
posed (Fig. 1). Chondroitinase ABC (1 U/ml in PBS) was added to the exposed
surface and incubated for periods up to 24 h at 37C. Following incubation, the
solution was removed and the explant washed three times in PBS.IMMUNOHISTOCHEMISTRYCartilage explants were orientated at 90 to the cut chondroitinase ABC
treated edge in order to obtain full depth cryosections (10 mm) (Bright Instru-
ment Co Ltd., UK), which were mounted on poly-L-lysine coated microscope
slides (BDH Laboratory Supplies, UK). Sections were rehydrated in PBS/
0.001% Tween (PBS-T) 20 for 10 min, before blocking with normal whole
goat serum (1:20 dilution; DakoCytomation, Glostrup, Denmark) for 30 min at
room temperature. Serum was replaced with primary antibodies recognising
chondroitinase-generated ‘‘CS-stubs’’ chondroitin-0 and 4-sulphate29,30,
using 1-B-5 and 2-B-6, respectively, and incubated overnight at 4C in a
humidiﬁed chamber. Sections were washed in PBS-T and incubated with
an anti-mouse ﬂuorescein isothiocyanate (FITC)-conjugated secondary anti-
body raised in goat (1:50 dilution; DakoCytomation, Glostrup, Denmark) for
1 h at room temperature. After repeated washes in PBS-T, sections were
mounted in Vectashield containing propidium iodide (Vector Laboratories
Inc., CA, USA). Sections were viewed using an upright ﬂuorescent micro-
scope (Laborlux 12, Leitz DRMB, Leica, Germany) at 40 magniﬁcation.CELL DEATH ASSAY: INCORPORATION OF ETHIDIUM
HOMODIMERThe effect of digesting cartilage explants with chondroitinase ABC (1 U/
ml, 8 h) on chondrocyte viability was assessed using a cell death assay.
Explants treated with chondroitinase ABC or PBS (controls) were incubated
with 2 mM ethidium homodimer in PBS for 1.5 h at 37C. Explants were
washed in PBS three times over 15 min before snap freezing in liquid nitro-
gen and cryosections visualised using a ﬂuorescence microscope at 20
magniﬁcation.FLUORESCENCE LABELLING OF ISOLATED ARTICULAR
CARTILAGE CHONDROCYTES50chloromethylﬂuorescein diacetate (CMFDA) (Molecular Probes Europe
BV, The Netherlands) was dissolved in anhydrous dimethylsulfoxide
(DMSO) and diluted in sterile PBS to provide a working concentration of
1.94 mM. Chondrocytes (1 107) were resuspended in CMFDA and incu-
bated at 37C for 1 h. Labelled chondrocytes were centrifuged (1800 RPM,
10 min), resuspended in culture media and seeded at 2 106 cells/ml directly
onto the chondroitinase ABC treated and control (PBS treated) explants em-
bedded in agarose as described above and cultured for periods up to 28 days.QUANTIFICATION OF CELL MIGRATION INTO ARTICULAR
CARTILAGE EXPLANTSThe number of CMFDA-labelled chondrocytes that had migrated into the
chondroitinase ABC digested and control articular cartilage explants was
quantiﬁed. Immunohistochemistry with antibodies 2-B-6 and 1-B-5 was per-
formed using the same protocol as previously described, except that sections
were blocked with whole donkey serum as a donkey anti-mouse Texas Red
conjugated secondary antibody (1:50 dilution; GE Healthcare UK Ltd., UK)
was used to visualise the CS-stubs. Sections were mounted in Vectashield.
Fig. 1. Schematic representation of the in vitro cartilage explant model for measuring chondrocyte migration and integration. The explant was
excised from the bovine metacarpophalangeal joint (1) and cut using a sharp scalpel blade (2). The excised cartilage was orientated to give
a full thickness exposed cut edge for chondroitinase ABC treatment (3) and embedded in agarose leaving only the cut edge exposed and ﬂush
with the surrounding agarose (4).
857Osteoarthritis and Cartilage Vol. 16, No. 8Grids of 0.1 mm2 were used to quantify the migration of labelled cells into the
explants over the 28-day culture period. The total number of labelled cells pres-
ent within the superﬁcial, transitional and deep zones of the explants was
counted. The mean S.E.M. was calculated for each group of samples and
all data were assessed for normal distribution using the AndersoneDarling
test (P> 0.05). Statistical signiﬁcance was calculated using a two-sample
t test.
The superﬁcial zone has been deﬁned as the region extending from the
articular surface to a depth of 100 mm into the tissue. The deep zone has
been deﬁned for this purpose as the region extending 100 mm above the start
of the subchondral bone.ResultsA SUB-POPULATION OF ARTICULAR CHONDROCYTES
DEMONSTRATE INCREASED MIGRATION ON
CHONDROITINASE ABC DIGESTED AGGRECANThe ability of young and mature chondrocytes to migrate
on aggrecan core protein e in the presence or absence of
CS chains, was assessed using the Boyden Chamber
model (Fig. 2). Of the chondrocytes seeded onto the upper-
most side of the chamber membranes, only 8% migrated to
the lower side of the membrane irrespective of chondrocyte
source. Both young [Fig. 2(A)] and mature [Fig. 2(B)] chon-
drocyte populations were able to migrate on aggrecan. In-
creased migration, for both age groups, was observed on
the chondroitinase ABC treated aggrecan when compared
to the native aggrecan substrate, however, this was only
signiﬁcant in the young cells after 24 h (P< 0.05).EXTENDED DIGESTION OF ARTICULAR CARTILAGE
IS NECESSARY TO REMOVE CS FROM THE CUT EDGEIn order to achieve sufﬁcient digestion within all the carti-
lage zones for the migration and integration of transplanted
cells without causing permanent damage to the cartilage,
optimisation of chondroitinase ABC concentration and incu-
bation time for digestion of the cartilage explants were per-
formed. Explants embedded in agarose were digested for
up to 24 h with 1 U/ml enzyme and the degree of digestion
ascertained immunohistochemically using the ‘‘CS-stub’’
neo-epitope antibodies 1-B-5 and 2-B-6 (Fig. 3).The rate and amount of digestion between zones var-
ied due to the differing concentrations of proteoglycans
within these zones. Digestion within the superﬁcial zone
of the cartilage explants was more extensive compared
to the other zones of the cartilage [Fig. 3(AeD)]. Chon-
droitinase ABC treatment of the tissue for 1 h did not ex-
tend the area of digestion beyond the cut surface within
the transitional [Fig. 3(E)] and deep zones [Fig. 3(I)]. At
4 h, further digestion was seen within the superﬁcial layer
[Fig. 3(B)], but within the deeper layers digestion of the
cartilage was still seen to be minimal [Fig. 3(F) and (J)].
An incubation period of 8 h resulted in sufﬁcient digestion
through all zones of the tissue. The depth of digestion
from the exposed surface had increased within all zones,
although digestion was far more limited in the transitional
[Fig. 3(G)] and deep zones [Fig. 3(K)] relative to the
superﬁcial zone of the cartilage explant [Fig. 3(C)]. After
a 24-h incubation period, complete digestion of the CS
chains was observed within the superﬁcial zone as evi-
denced by a blanket of chondroitinase ABC generated
CS-stubs [Fig. 3(D)]. Increased staining was also ob-
served in the transitional [Fig. 3(H)] and deep zone
[Fig. 3(L)]. To preserve a balance between digestion
and tissue damage, an optimal concentration of 1 U/ml
chondroitinase ABC for an incubation period of 8 h was
chosen for subsequent experiments using this in vitro
model for chondrocyte migration studies.CHONDROITINASE ABC DIGESTION OF ARTICULAR
CARTILAGE DOES NOT INDUCE CELL DEATHTo determine the extent of cell death in the explants after
incubation with chondroitinase ABC, digested explants
were labelled with ethidium homodimer which is only taken
up by dead cells (red). Cell death was observed at the cut
edge and in the deep zone of the chondrocytes after diges-
tion with chondroitinase ABC for 8 h [Fig. 4(A)]. The amount
of cell death in explants treated with PBS was utilised as
a negative control; cell death was only observed at the
cut edge and in the deep zone [Fig. 4(B)] indicating that
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Fig. 2. Numbers of chondrocytes isolated from (A) young and (B) mature articular cartilages migrating on native and chondroitinase ABC
digested aggrecan over 24 h. Values are expressed S.E.M. (n¼ 3) *P< 0.05.
858 L. C. Davies et al.: CS impedes migration in a sub-population of chondrocyteschondroitinase ABC did not directly induce any additional
cell death.A SUB-POPULATION OF ARTICULAR CHONDROCYTES
MIGRATE INTO CHONDROITINASE ABC DIGESTED
EXPLANTS IN A TIME DEPENDENT MANNERTo determine the extent of cell migration into the chondroi-
tinase ABC digested cartilage explants, chondrocytes were
labelled with CMFDA and monitored using ﬂuorescence
microscopy. In agreement with results from the Boyden
chamber experiments (Fig. 2), CS chains on the aggrecan
core protein inhibit the migration of isolated chondrocytes
into the cut edge of young articular cartilage explants
[Figs. 5(B) and 6(B)]. Minimal migration of CMFDA-labelled
chondrocytes, isolated from both young [Fig. 5(A)] and ma-
ture [Fig. 6(A)] articular cartilages, was observed in the con-
trol explants over the initial 7-day culture period. In explants
cultured for longer than 14 days, a small amount of migration
into the superﬁcial and transitional zones of the control ex-
plants was observed where concentrations of proteoglycans
are at their lowest [Figs. 5(A) and 6(A)]. In comparison, there
was a marked migration of young [Fig. 5(B)] and mature
[Fig. 6(B)] CMFDA-labelled chondrocytes into the chondroiti-
nase ABC digested explants. Migration was only observed in
the zone of digestion, although CMFDA-labelled chondro-
cytes were also observed at the cut edge. The majority of
the chondrocytes that had migrated into the tissue wereobserved within the superﬁcial zone, consistent with the
greater degree of digestion within this region. In comparison
to the superﬁcial and transitional zones, active migration of
chondrocytes into the deeper zones was substantially less
[Figs. 5(B) and 6(B)].
Grids were used to quantify the number of CMFDA-
labelled chondrocytes that had migrated into the superﬁ-
cial, transitional and deep zones of the cut articular
cartilage explants. Increasing numbers of labelled chon-
drocytes isolated from both young [Fig. 5(C)] and mature
[Fig. 6(C)] articular cartilages were demonstrated to mi-
grate into the chondroitinase ABC digested explants
with time in culture [Fig. 5(C)]. This trend appeared to
plateau after 14 days with the chondrocytes isolated
from the young articular cartilage [Fig. 5(C)]. In contrast,
the number of chondrocytes isolated from the mature car-
tilage that had migrated into the digested explants contin-
ued to increase to day 28 [Fig. 6(C)]. Statistical analysis
conﬁrmed signiﬁcantly higher numbers of CMFDA-labelled
mature chondrocytes in the chondroitinase ABC digested
explants at days 7, 14 and 28 when compared to controls
(P< 0.005, 0.5 and 0.001, respectively). Initially fewer
CMFDA-labelled chondrocytes isolated from the mature
articular cartilage were seen to migrate into the cut ex-
plants when compared to chondrocytes isolated from
the young cartilage. At later time points the numbers of
labelled chondrocytes within the digested explants were
comparable between the age groups.
Fig. 3. Immunoﬂuorescence photomicrographs, using monoclonal antibodies 1-B-5 and 2-B-6, demonstrating the presence of chondroitinase
ABC generated CS-stubs originating from the exposed cut edge (white dotted line). CS-stub formation is present in the superﬁcial (AeD),
transitional (EeH) and deep (IeL) zones of the articular cartilage explant, with increasing depth from the cut edge with time in culture (up
to 24 h). Chondroitinase ABC generated CS-stubs are labelled with FITC (green) and nuclei counterstained with propidium iodide (red).
Bar¼ 50 mm.
Fig. 4. Fluorescence photomicrographs illustrating ethidium homodimer (dead) labelled chondrocytes within full depth articular cartilage (A) 8 h
chondroitinase ABC treated and (B) PBS treated explants. The cut edge is depicted by a white dotted line. SZ¼ superﬁcial zone and
DZ¼ deep zone. Bar¼ 50 mm.
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Fig. 6. Immunoﬂuorescence photomicrographs demonstrating the migration of CMFDA-labelled mature articular chondrocytes into (A) PBS
control and (B) chondroitinase ABC digested explants over 28 days in culture. The antibodies 2-B-6 and 1-B-5 and a secondary Texas
Red conjugated antibody have been used to highlight the chondroitinase ABC generated CS-stubs (scale bar¼ 50 mm). The cut edge is
depicted by a white dotted line. (C) Quantiﬁcation of migrating CMFDA-labelled chondrocytes (green) visualised in (A) and (B). Data are
presented as mean S.E.M. (n¼ 3; *P< 0.05, **P< 0.01, ***P< 0.001).
862 L. C. Davies et al.: CS impedes migration in a sub-population of chondrocytesMIGRATING ARTICULAR CHONDROCYTES ADOPT THE
MORPHOLOGY OF RESIDENT ARTICULAR CHONDROCYTESThe morphology of the CMFDA-labelled chondrocytes
that had migrated into the different zones of the cut cartilage
explants was assessed using ﬂuorescence microscopy
(Fig. 7). By day 21, the CMFDA-labelled chondrocytes
that had migrated into the explant tissue demonstrated the
morphology of the resident cells of the zones that they
had migrated into and were occupying lacunae (Fig. 7). In
particular, labelled chondrocytes within the superﬁcial
zone were ﬂattened and arranged in rows parallel to the ar-
ticular surface of the explant [Fig. 7(A) and (B)]. Within the
transitional zone migrated chondrocytes demonstrated
a more spherical morphology and were randomly distrib-
uted within the extracellular matrix [Fig. 7(C) and (D)]. The
lacunae were clearly visible within both the transitional
and the deep zone. Labelled chondrocytes within the
deep zone were spherical and occupied lacunae; these
cells were arranged in columns perpendicular to theFig. 7. High magniﬁcation ﬂuorescence photomicrographs of migrated CM
articular cartilages into the superﬁcial (AeB), transitional (CeD) and deep
explants. Arrowheads indicate migrated chondrocytes displaying charactearticular surface and aligned with the resident chondrocytes
within the explants [Fig. 7(E) and (F)].Discussion
We have demonstrated for the ﬁrst time that a sub-
population of primary chondrocytes isolated from both young
and skeletally mature articular cartilages has the ability to mi-
grate into native articular cartilage that has been pre-treated
with chondroitinase ABC. Although the use of chondroitinase
ABC in enhancing migration of synoviocytes in a partial-
thickness defect in an in vivo rabbit model has been previ-
ously described21, we report, for the ﬁrst time, the ability of
migrating chondrocytes to adopt the cellular morphology
and inherent characteristics of the resident tissue that has
been subject to the chondroitinase ABC digestion.
Using both a Boyden chamber model of cell migration
and an in vitro full thickness articular cartilage explant
model we have shown that CS on aggrecan impedes theFDA-labelled chondrocytes (green) isolated from young and mature
(EeF) zones of the chondroitinase ABC treated articular cartilage
ristic morphology of cells within their respective zones. Bar¼ 10 mm.
863Osteoarthritis and Cartilage Vol. 16, No. 8migration of articular chondrocytes and that prolonged di-
gestion of cartilage with chondroitinase ABC promotes the
migration of isolated chondrocytes into the digested matrix.
Our data, using the Boyden chamber assay, suggest that
there is a sub-population of cells within cartilage that has
signiﬁcantly greater migratory potential than the bulk of cells
as only 8% of the chondrocytes seeded onto the uppermost
side of the chamber membranes, migrated to the lower side.
This was true for both age groups of chondrocytes. This
may relate to the identiﬁcation of a chondroprogenitor cell
population within the superﬁcial zone of articular cartilage31.
At present there are no clear markers for this progenitor cell
although their colony forming potential could be determined.
The potential of this progenitor cell for cartilage repair has
yet to be fully assessed32.
The anti-adhesive properties of proteoglycans have previ-
ously been demonstrated15 and speciﬁcally this is thought to
be due to the presence of their sGAG chains12e14,16,17. The
sGAG chain component has been shown directly to have an
anti-migratory effect on ﬁbroblasts14, endothelial cells19,
nerve cells20 and synoviocytes21. Using the Boyden cham-
ber assay we have demonstrated that a chondrocyte sub-
population can migrate on aggrecan coated membranes
and that removal of theCS glycosaminoglycan (GAG) chains
enhanced their migratory capacity. The concentration of
GAGs in articular cartilage is approximately 50 mg/ml33
which exhibits both anti-adhesive and anti-migratory proper-
ties. However, the concentration of aggrecan used in this as-
say was only 50 mg/ml which is too low a concentration to
prevent adhesion and migration of the chondrocytes thus
limiting the effect of chondroitinase ABC digestion. There-
fore, we used a cartilage explant model to investigate the
role of the GAG chains in inhibiting chondrocyte migration.
Initially we had to ascertain appropriate chondroitinase
ABC digestion conditions to denude the endogenous aggre-
can of the CS GAGs. We utilised antibodies that speciﬁcally
recognise the GAG ‘‘stubs’’ remaining after chondroitinase
ABC digestion to determine the extent of digestion; a cell
death assay was also used to determine the effect of this
digestion on the viability of the explants after digestion. As ex-
pected, digestion of the surface zone, where the proteogly-
can concentration is relatively low, was readily achieved but
more extensive digestion was necessary to obtain signiﬁcant
removal of the CS chains from the deep zone. An incubation
period of 8 h appeared to be optimal for digestion through all
zones of the tissue. Although digestion was more limited in
the transitional and deep zones in comparison to that of the
superﬁcial zone of the explant allowing an incubation period
of 24 h resulted in complete digestion of the CS chains within
the superﬁcial zone with a blanket of chondroitinase ABC
generated CS-stubs being seen. Complete digestion in
such a manner could ultimately result in permanent damage
to the cartilage and the ability of the cartilage to withstand
compressive forces would be diminished.
Cell death induced by chondroitinase ABC digestion of
the explants was not observed. Additionally, limited cell
death is seen at the cut edge caused by excision of the tis-
sue with a scalpel blade in accordance with previous stud-
ies34,35. As expected the zone of cell death within the deep
zone was largest, a factor that can be attributed to cell
death induced during removal of the explant from the
bone for experimentation. No further cell death was seen
deeper into the tissue than that demonstrated in the PBS
treated control explants that can be correlated with diges-
tion of the tissue with chondroitinase ABC.
This optimised in vitro model was subsequently used to
visualise the migration of CMFDA-labelled chondrocytesinto articular cartilage explants. Negligible migration of
CMFDA-labelled chondrocytes from both young and mature
articular cartilages was visualised in control explants over
the ﬁrst 7 days in culture conﬁrming the anti-adhesive/
anti-migratory nature of native articular cartilage6,15. At the
later time points a small amount of migration was observed
in the superﬁcialetransitional zones of the control explants
where concentrations of proteoglycans are at their lowest33.
This was expected as this is a static model of migration. As
previously demonstrated within a number of models, immo-
bilisation of a synovial joint leads to loss of proteoglycans
from the articular cartilage, allowing the migration of isolated
chondrocytes into the matrix36e42.
In comparison, labelled chondrocytes from both age
groups migrated into chondroitinase ABC digested explants,
with increasing numbers of labelled cells observed within the
digested matrix with time in culture. This migration only ex-
tended as far as the zone of digestion, demonstrating the in-
hibitory effect of the CS GAG chains. Quantitative analysis
shows that the total number of chondrocytes migrating com-
pared to undigested controls is statistically signiﬁcant in
many cases, especially with the mature chondrocytes, but
clear trends are also observed with the cells derived from
young cartilage. In most cases the variability is quite high
and the number of total cells is quite low, therefore n¼ 3 is
insufﬁcient to achieve statistical signiﬁcance. Analysis by
zone showed, as expected, that most cells migrated into
the superﬁcial zone but this again only reached signiﬁcance
with the mature cells after 14 and 28 days. Interestingly, at
the early time points a sub-population of young cells clearly
migrate more rapidly than the cells derived from mature car-
tilage. However, in both cases the number of cells plateaus
at a similar level again suggesting that there is a limited pop-
ulation of chondrocytes capable of adhering to and migrating
into the explants consistent with the Boyden chamber data.
Whether the removal of GAGs abolishes the inhibitory activ-
ity of the proteoglycans or unmasks other pro-adhesive/pro-
migratory matrix macromolecules, such as ﬁbronectin and
type II collagen is at present unknown.
Interestingly by days 21 and 28, ﬂuorescently labelled mi-
grated chondrocytes were demonstrating the correct cellular
morphology for the zones into which they had migrated. La-
belled chondrocyteswithin the superﬁcial zonewere typically
ﬂattened and arranged in rows parallel to the articular sur-
face. Cells within the transitional and deep zones were
more spherical with a random distribution in the transitional
zone, and in columns perpendicular to the articular surface
within the deep zone. Migrated chondrocytes can clearly be
seen to occupy lacunae within transitional and deep zones.
This is the ﬁrst study to demonstrate that chondrocytes
migrating into an established articular cartilage matrix can
adapt to the morphology of the resident chondrocytes al-
though a recent study of neocartilage grafts produced in cul-
ture also adopted a zonal organisation similar to native
cartilage43. In our current study, the morphology of the la-
belled chondrocytes is likely to have been inﬂuenced by
the organisation of the matrix of the cartilage explant.
Clearly, removal of GAGs by chondroitinase ABC appears
not to have signiﬁcantly affected this matrix organisation
suggesting that once the proteoglycans have been replaced
the cartilage will retain its normal biomechanical properties.
Effective tissue integration of cartilage grafts with endoge-
nous cartilage requires adequate and appropriate matrix
synthesis that is assembled across the repair interface. We
have previously demonstrated that a combination of IGF-1
and TGFb1 enhances cartilage matrix biosynthesis in skele-
tally mature articular chondrocytes (Davies et al., submitted).
864 L. C. Davies et al.: CS impedes migration in a sub-population of chondrocytesUsing this in vitro model we have clearly demonstrated that
removal of CS GAG chains at the edge of a cartilage defect
promotes chondrocyte migration, without adversely affecting
cell viability or morphology, and therefore is likely to be
advantageous in promoting a more effective repair. A combi-
nation of these two strategies has the potential to greatly
reduce the incidence of poor cartilage graft integration, a
major problem in current cartilage repair strategies.
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